Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POU domain class 5, transcription factor 2 (POU5F2) is a protein-coding gene encoding a transcription factor that binds preferentially to the octamer motif (5'-ATGTTAAT-3'). It is predicted to play a regulatory role in meiotic events that are important for the terminal differentiation of male germ cells. POU5F2 is part of the POU domain protein family (class V), which are characterized by containing a homeodomain joined to a POU-specific DNA-binding domain, enabling specific sequence recognition and regulation of gene expression. Although it is classified as a transcription factor, there is currently no evidence supporting its role as a direct therapeutic target nor are there drugs or biomarkers specifically associated with this molecule. POU5F2 is related to, but distinct from, POU5F1 (OCT4), a known key regulator of pluripotency. Disease associations include certain syndromic optic atrophies and some cancer linkages, but these are not well characterized or validated as clinical targets. There are no notable safety concerns or therapeutic challenges described for this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POU domain class 5, transcription factor 2 (POU5F2).